Skip to main content

Table 4 Five-year survival estimates by expression levels of translational regulators.

From: Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer

   N Events Five-year estimate 95% CI Pvalue
RFS       
p4E-BP1 S65 High 8 7 37.5% (15.3%, 91.7%)  
  Low 180 40 88.7% (83.9%, 93.8%) <0.0001
OS       
pS6 S235/236 High 11 6 52.6% (26.1%, 100%)  
  Low 177 59 87.9% (82.7%, 88.8%) 0.0001
eEF2K High 126 51 79.0% (71.8%, 86.9%)  
  Low 62 14 85.9% (77.3%, 95.5%) 0.0424
Pdcd4 High 78 16 91.5% (85.2%, 98.3%)  
  Low 110 49 74.2% (66.2%, 83.4%) 0.0021
  1. CI, confidence interval; OS, overall survival; RFS, recurrence-free survival.
\